Objectives: Proper assessment of the intracranial arteries by transcranial color-coded duplex sonography (TCCD) is occasionally made difficult by an insufficient temporal bone window, an unfavorable insonation angle, or low flow velocity or volume. In these cases, echocontrast could be helpful to increase the diagnostic confidence or to make the diagnosis at all. Material and Methods: We investigated 67 temporal windows of 47 patients with insufficient native transtemporal insonation conditions before and after the application of the second-generation (gas-filled) microbubble contrast agent Sonovue® (in 20 patients out of these 47, both temporal windows were insufficient, in the remaining 27 only one side). Results: As compared to the precontrast scans, echocontrast allowed for more segments to be evaluated by pulsed Doppler sonography (p < 0.0001) and for longer lumen segments to be displayed on color mode (p < 0.0001). With the help of contrast medium, flow velocity in the middle cerebral artery could be measured through 65 windows as compared to only 26 windows before contrast was applied (p < 0.0001). Conclusions: In patients with poor precontrast visualization of intracranial arteries, echocontrast-enhanced TCCD is very helpful.

1.
Baumgartner RW, Mathis J, Sturzenegger M, Mattle HP: A validation study on the intraobserver reproducibility of transcranial color-coded duplex sonography velocity measurements. Ultrasound Med Biol 1994;20:233–237.
2.
Bogdahn U, Becker G, Winkler J, Greiner K, Perez J, Meurers B: Transcranial color-coded real-time sonography in adults. Stroke 1990;21:1680–1688.
3.
Goertler M, Kross R, Baeumer M, Jost S, Grote R, Weber S, et al: Diagnostic impact and prognostic relevance of early contrast-enhanced transcranial color-coded duplex sonography in acute stroke. Stroke 1998;29:955–962.
4.
Kaps M, Seidel G, Bauer T, Behrmann B: Imaging of the intracranial vertebrobasilar system using color-coded ultrasound. Stroke 1992;23:1577–1582.
5.
Nabavi DG, Droste DW, Schulte Altedorneburg G, Kemeny V, Panzica M, Weber S, et al: Diagnostic benefit of echocontrast enhancement for the insufficient transtemporal bone window. J Neuroimag 1999;9:102–107.
6.
Gahn G, Gerber J, Hallmeyer S, Hahn G, Ackerman RH, Reichmann H, et al: Contrast-enhanced transcranial color-coded duplex sonography in stroke patients with limited bone windows. AJNR 2000;21:509–514.
7.
Gerriets T, Seidel G, Fiss I, Modrau B, Kaps M: Contrast-enhanced transcranial color-coded duplex sonography: efficiency and validity. Neurology 1999;52:1133–1137.
8.
Greis C: Technology overview: Sonovue (Bracco, Milan). Eur Radiol 2004;14(suppl 8):P11–P15.
9.
Droste DW, Metz RJ: Clinical utility of echocontrast agents in neurosonology. Neurol Res 2004;26:754–759.
10.
Bokor D: Diagnostic efficacy of Sonovue. Am J Cardiol 2000;86:19G–24G.
11.
Droste DW, Llull JB, Pezzoli C, Bogdahn U, Kaps M: Sonovue® (BR1), a new long-acting echocontrast agent, improves transcranial colour-coded duplex ultrasonic imaging. Cerebrovasc Dis 2002;14:27–32.
12.
Correas JM, Burns PN, Lai X, Qi X: Infusion versus bolus of an ultrasound contrast agent: in vivo dose-response measurements of BR1. Invest Radiol 2000;35:72–79.
13.
Baumgartner RW, Arnold M, Gonner F, Staikow I, Herrmann C, Rivoir A, et al: Contrast-enhanced transcranial color-coded duplex sonography in ischemic cerebrovascular disease. Stroke 1997;28:2473–2478.
14.
Droste DW, Jürgens R, Weber S, Tietje R, Ringelstein EB: Benefit of echocontrast-enhanced transcranial color-coded duplex ultrasound in the assessment of intracranial collateral pathways. Stroke 2000;31:920–923.
15.
Gerriets T, Goertler M, Stolz E, Postert T, Sliwka U, Schlachetzki F, et al: Feasibility and validity of transcranial duplex sonography in patients with acute stroke. J Neurol Neurosurg Psychiatr 2002;73:17–20.
16.
Hansberg T, Wong KS, Droste DW, Ringelstein EB: Effects of the ultrasound contrast-enhancing agent Levovist on the detection of intracranial arteries and stenoses in Chinese by transcranial Doppler ultrasound. Cerebrovasc Dis 2003;14:105–108.
17.
Nabavi DG, Droste DW, Kemény V, Schulte-Altedorneburg G, Weber S, Ringelstein EB: Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients: a pilot study. Stroke 1998;29:949–954.
18.
Postert T, Braun B, Meves S, Koster O, Przuntek H, Weber S, et al: Contrast-enhanced transcranial color-coded sonography in acute hemispheric brain infarction. Stroke 1999;30:1819–1826.
19.
Zunker P, Wilms H, Brossmann J, Georgiadis D, Weber S, Deuschl G: Echo contrast-enhanced transcranial ultrasound: frequency of use, diagnostic benefit, and validity of results compared with MRA. Stroke 2003;33:2600–2603.
20.
Khaffaf N, Karnik R, Winkler WB, Valentin A, Slany J: Embolic stroke by compression maneuver during transcranial Doppler sonography. Stroke 1994;25:1056–1057.
21.
Mast H, Ecker S, Marx P: Cerebral ischemia induced by compression tests during transcranial Doppler sonography. Clin Invest 1993;71:46–48.
22.
Ringelstein EB, Weiller C, Weckesser M, Weckesser S: Cerebral vasomotor reactivity is significantly reduced in low-flow as compared to thromboembolic infarctions: the key role of the circle of Willis. J Neurol Sci 1994;121:103–109.
23.
Doblar DD, Plyushcheva NV, Jordan W, McDowell H: Predicting the effect of carotid artery occlusion during carotid endarterectomy: comparing transcranial Doppler measurements and cerebral angiography. Stroke 1998;29:2038–2042.
24.
Lopez Bresnahan MV, Kearse LA Jr, Yanez P, Young TI: Anterior communicating artery collateral flow protection against ischemic change during carotid endarterectomy. J Neurosurg 1993;79:379–382.
25.
Schneider PA, Ringelstein EB, Rossman ME, Dilley RB, Sobel DF, Otis SM, et al: Importance of cerebral collateral pathways during carotid endarterectomy. Stroke 1988;19:1328–1334.
26.
Schneider PA, Rossman ME, Bernstein EF, Torem S, Ringelstein EB, Otis SM: Effect of internal carotid artery occlusion on intracranial hemodynamics: transcranial Doppler evaluation and clinical correlation. Stroke 1988;19:589–593.
27.
Berrouschot J, Barthel H, von Kummer R, Knapp WH, Hesse S, Schneider D: 99(m)Technetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke 1998;29:2556–2562.
28.
Berrouschot J, Sterker M, Bettin S, Koster J, Schneider D: Mortality of space-occupying (‘malignant’) middle cerebral artery infarction under conservative intensive care. Intensive Care Med 1998;24:620–623.
29.
Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, et al: Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998;29:1888–1893.
30.
Gebel M, Caselitz M, Bowen-Davies PE, Weber S: A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 A (Levovist) for Doppler signal enhancement in the portal vascular system. Ultraschall Med 1998;19:148–156.
31.
Hankey GJ, Warlow C, Sellar RJ: Cerebral angiographic risk in mild cerebrovascular disease. Stroke 1990;21:209–222.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.